Upfront stereotactic radiosurgery for large posterior fossa metastases: a multicenter evaluation of clinical outcomes - Top-Institutions - MDSpire

Upfront stereotactic radiosurgery for large posterior fossa metastases: a multicenter evaluation of clinical outcomes

  • By

  • Ben-Shoshan, Ariel

  • Heymann, Sami

  • Asprilla, José

  • Kelmer, Paz

  • Moscovici, Samuel

  • Hillman, Yair

  • Weizman, Noam

  • Bohbot, Rotem

  • Wohl, Anton

  • Cohen, Zvi R.

  • Lawrence, Yaacov R.

  • Wygoda, Marc

  • Shoshan, Yigal

  • Kaisman-Elbaz, Tehila

  • Falick Michaeli, Tal

  • March 2, 2026

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Neurosurgery

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Radiation Oncology
    • Neurosurgery

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Radiation Oncology
    • Neuro-oncology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neuro-oncology
    • Neurosurgery
    • Radiation Oncology

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurosurgery
    • Radiation Oncology
    • Neuro-oncology

Original Source(s)

Upfront stereotactic radiosurgery for large posterior fossa metastases: a multicenter evaluation of clinical outcomes

  • by Ben-Shoshan, Ariel, Heymann, Sami, Asprilla, José, Kelmer, Paz, Moscovici, Samuel, Hillman, Yair, Weizman, Noam, Bohbot, Rotem, Wohl, Anton, Cohen, Zvi R., Lawrence, Yaacov R., Wygoda, Marc, Shoshan, Yigal, Kaisman-Elbaz, Tehila, Falick Michaeli, Tal

  • March 2, 2026

Related Content

NLRP3 inflammasomes at the ARDS-cancer interface: mechanisms and translational hypotheses

PARylation-centric crosstalk: orchestrating immune evasion and multidrug resistance in ovarian cancer

Cervical Cancer Trends Differ by Age

Recent declines among women younger than 35 years contrasted with rising long-term incidence among women aged 35 to 49 years in Puerto Rico